Genesis Therapeutics | Menlo Ventures
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.| Menlo Ventures
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.| Menlo Ventures
Menlo Ventures is an early-stage venture capital firm that invests across AI, consumer, enterprise, and healthcare technologies.| Menlo Ventures
A year after launching our Anthology Fund, a $100M initiative in partnership with Anthropic, we’re excited to share a Q2 2025 update on our progress.| Menlo Ventures
Chai Discovery is building foundation models for biology and drug discovery to transform how biopharma creates new therapies.| Menlo Ventures
As foundation models’ capabilities and economics evolve, so will the systems, applications, and industries built on top of them.| Menlo Ventures
Securing agentic systems requires rethinking everything from authentication to observability. A new playbook is emerging: security for agents.| Menlo Ventures
At Menlo Ventures, we have our own point of view on the people, technologies, and conversations that will shape the future.| Menlo Ventures
Based on a survey of over 5,000 U.S. adults, Menlo Ventures unpacks consumer AI adoption in 2025, with key takeaways for founders.| Menlo Ventures
We are thrilled to announce our investment in OpenRouter: one API, centralized billing, and access to 400+ AI models across 60+ providers.| Menlo Ventures
Wispr is developing a foundational voice layer for technology—a fluid, intelligent, and genuinely intuitive interface for all humans.| Menlo Ventures
Anthropic is an AI safety and research company that builds reliable, interpretable, and steerable AI systems.| Menlo Ventures
The Anthology Fund is a $100 million initiative between Menlo Ventures and Anthropic to fund world-changing AI companies.| Menlo Ventures
The enterprise AI landscape is being rewritten in real time. We surveyed 600 U.S. enterprise IT decision-makers to reveal the emerging winners and losers.| Menlo Ventures
In the race to adopt generative AI, every enterprise grapples with a common concern: security.| Menlo Ventures
More than ever, machines are capable of reasoning, creation, and creativity—driving enterprises to reconstruct their tech stacks.| Menlo Ventures
Menlo Ventures surveyed more than 450 enterprise executives to provide a view into generative AI adoption in the enterprise today.| Menlo Ventures
